↓ Skip to main content

Cochrane Database of Systematic Reviews

Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease

Overview of attention for article published in Cochrane database of systematic reviews, October 2006
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

blogs
1 blog
twitter
2 X users

Citations

dimensions_citation
227 Dimensions

Readers on

mendeley
199 Mendeley
citeulike
1 CiteULike
Title
Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease
Published in
Cochrane database of systematic reviews, October 2006
DOI 10.1002/14651858.cd006257
Pubmed ID
Authors

Giovanni FM Strippoli, Carmen Bonifati, Maria E Craig, Sankar D Navaneethan, Jonathan C Craig

Abstract

Angiotensin converting enzyme inhibitors (ACEi) and angiotensin II receptor antagonists (AIIRA) are considered to be equally effective for patients with diabetic kidney disease (DKD), but renal and not mortality outcomes have usually been considered.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 199 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Japan 1 <1%
United States 1 <1%
Unknown 196 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 36 18%
Researcher 25 13%
Other 16 8%
Student > Bachelor 16 8%
Student > Postgraduate 15 8%
Other 37 19%
Unknown 54 27%
Readers by discipline Count As %
Medicine and Dentistry 97 49%
Nursing and Health Professions 10 5%
Pharmacology, Toxicology and Pharmaceutical Science 8 4%
Agricultural and Biological Sciences 8 4%
Social Sciences 3 2%
Other 17 9%
Unknown 56 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 February 2023.
All research outputs
#4,331,161
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#6,635
of 11,499 outputs
Outputs of similar age
#12,378
of 84,801 outputs
Outputs of similar age from Cochrane database of systematic reviews
#25
of 72 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. Compared to these this one has done well and is in the 82nd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 42nd percentile – i.e., 42% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 84,801 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 72 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.